As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Torrelles, Jordi B
Funded by
National Institutes of Health
Collaborating Institutions
Triterpenoid Therapeutics Inc
For this proposal, we will be responsible for the experiments involving infection of K18 hACE2 mice with SARS-CoV-2 USA-WA1/2020 strain and assess the effectivity of a drug compound provided by the partnering company.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Ross, Corinna
Funded by
National Institutes of Health
As the human population shifts to a higher proportion of aged and geriatric individuals, it is critical that we develop appropriate animal models in which to test interventional methods to maintain human health and to systemically treat age-related disease. Marmosets offer a unique model in which to evaluate the translational gap between cellular aging and clinical application.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
Janssen Pharmaceuticals, Inc.
The major goal of this study is to evaluate the cellular immune response in macaques vaccinated with an anti-heme vaccine.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Liu, Aimin
Funded by
NIH Natl Inst General Medical Sci
This application is a request of the administrative supplement funds to the above parent grant to support a Hispanic graduate student. Mr. Samuel L. Montoya. for his graduate study in the Department of Chemistry at The University of Texas at San Antonio. A 24-month of financial support is budgeted for providing Mr. Montoya with salaries. tuition support. health insurance. and support of research-related training activities such as workshops and scientific conferences.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
59th Medical Wing at the Wilford Hall Ambulatory Surgical Center (WHASC)
The 59th Medical Wing Chief Scientist provides the strategic vision, direction, oversight, project management support and technical resources to advance medical modernization efforts with a unique focus on research activities.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Turner, Joanne
Funded by
National Institutes of Health
The major goal of the project is to understand COVID-19 in the elderly for the development of cures or vaccines.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Torrelles, Jordi B
Funded by
Bill & Melinda Gates Foundation
The overall scope of the study is to determine if human monoclonal antibodies (hmAbs) shown in vitro to block SARS-CoV-2 infection are also effective, alone or in combination, in vivo using two rodent animal models of SARS-CoV-2 infection and associated COVID-19 disease.
